scholarly article | Q13442814 |
retracted paper | Q45182324 |
P819 | ADS bibcode | 2011PLoSO...622244D |
P356 | DOI | 10.1371/JOURNAL.PONE.0022244 |
P932 | PMC publication ID | 3136522 |
P698 | PubMed publication ID | 21779402 |
P5875 | ResearchGate publication ID | 51511835 |
P50 | author | Michael DeNiro | Q80670475 |
P2093 | author name string | Falah H Al-Mohanna | |
Futwan A Al-Mohanna | |||
P2860 | cites work | Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel | Q46113784 |
Inhibition of GFAP synthesis by antisense RNA in astrocytes | Q46603239 | ||
EXPRESSION OF PLATELET-DERIVED GROWTH FACTOR IN AND AROUND INTRASTRIATAL EMBRYONIC MESENCEPHALIC GRAFTS. | Q47681026 | ||
Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide | Q47910766 | ||
The 14-year incidence of visual loss in a diabetic population | Q47971799 | ||
Astrocytes in Alzheimer's disease express immunoreactivity to the vaso-constrictor endothelin-1. | Q48159715 | ||
Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: analysis of expression, proliferation, and tumorigenicity | Q48239413 | ||
Possible association of platelet-derived growth factor (PDGF) with the appearance of reactive astrocytes following brain injury in situ | Q48298549 | ||
Astrogliosis in culture: I. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis | Q48331896 | ||
Reaction of Müller cells after increased intraocular pressure in the rat retina | Q48391127 | ||
Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage | Q48651901 | ||
A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans | Q48791964 | ||
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors | Q24676378 | ||
The Müller (glial) cell in normal and diseased retina: a case for single-cell electrophysiology | Q28250626 | ||
Intracerebroventricular administration of an endothelin ETB receptor agonist increases expression of tissue inhibitor of matrix metalloproteinase-1 and -3 in rat brain | Q28571424 | ||
Platelet-derived growth factor B-chain-like immunoreactivity in injured rat brain | Q28576736 | ||
Synemin is expressed in reactive astrocytes in neurotrauma and interacts differentially with vimentin and GFAP intermediate filament networks | Q28587008 | ||
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia | Q29617501 | ||
Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor | Q30631779 | ||
Müller cell activation, proliferation and migration following laser injury | Q33505318 | ||
Astrocyte activation and reactive gliosis | Q34413317 | ||
Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction | Q34564998 | ||
Regulation of nitric oxide-sensitive guanylyl cyclase | Q35185117 | ||
Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization | Q35745444 | ||
Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment | Q35829410 | ||
YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase | Q35872795 | ||
Collective cell migration in morphogenesis and cancer | Q35878896 | ||
Müller cells in the healthy and diseased retina | Q36535340 | ||
Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway | Q37226465 | ||
Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally | Q37696056 | ||
Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression | Q38329502 | ||
Reactive nitrogen intermediates in human neuropathology: an overview | Q40399434 | ||
Synthesis of nitric oxide in CNS glial cells. | Q40490204 | ||
Early breakdown of the blood-retinal barrier in diabetes | Q41681448 | ||
PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model | Q41699855 | ||
YC-1, a novel activator of platelet guanylate cyclase | Q42275468 | ||
Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis | Q42456475 | ||
Chemotaxis of rat brain astrocytes to platelet derived growth factor | Q42814250 | ||
Taurine buffers glutamate homeostasis in retinal cells in vitro under hypoxic conditions | Q43059284 | ||
Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy | Q43222825 | ||
Retinal vascular permeability determined by dual-tracer fluorescence angiography | Q43737046 | ||
Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. | Q43871268 | ||
Sources of PDGF expression in murine retina and the effect of short-term diabetes. | Q44699379 | ||
Glial reactivity, an early feature of diabetic retinopathy. | Q50511477 | ||
Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration. | Q52579934 | ||
Retinal astrocytes are immigrants from the optic nerve | Q59072118 | ||
[Proliferation of retinal glia and excitatory amino acids] | Q68619893 | ||
Glial fibrillary acidic protein increases in Müller cells after retinal detachment | Q68943510 | ||
Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells | Q70083229 | ||
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years | Q70330511 | ||
Müller cell expression of glial fibrillary acidic protein after genetic and experimental photoreceptor degeneration in the rat retina | Q70389133 | ||
Oxygen-induced retinopathy in the mouse | Q71608431 | ||
Increase of protein tyrosine phosphorylation in rat retina after ischemia-reperfusion injury | Q71620675 | ||
PDGF-BB induced chemotaxis is impaired in aged capillary endothelial cells | Q72123268 | ||
Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases | Q72196215 | ||
Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma | Q72393651 | ||
Müller cell protection of rat retinal ganglion cells from glutamate and nitric oxide neurotoxicity | Q73006488 | ||
Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy | Q73013059 | ||
Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats | Q73080753 | ||
Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis | Q73154123 | ||
Neuritic outgrowth associated with astroglial phenotypic changes induced by antisense glial fibrillary acidic protein (GFAP) mRNA in injured neuron-astrocyte cocultures | Q73340676 | ||
Mechanism of YC-1-induced activation of soluble guanylyl cyclase | Q74095219 | ||
Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group | Q74551598 | ||
Relationship between S100beta and GFAP expression in astrocytes during infarction and glial scar formation after mild transient ischemia | Q80489465 | ||
Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats | Q80972905 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e22244 | |
P577 | publication date | 2011-07-14 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Inhibition of reactive gliosis prevents neovascular growth in the mouse model of oxygen-induced retinopathy | |
Retracted: Inhibition of Reactive Gliosis Prevents Neovascular Growth in the Mouse Model of Oxygen-Induced Retinopathy | |||
P478 | volume | 6 |
Q41817953 | A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization |
Q33934830 | Activation of the TRPV1 cation channel contributes to stress-induced astrocyte migration |
Q97892616 | Ferrochelatase regulates retinal neovascularization |
Q38825960 | HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies |
Q58701214 | NCK-dependent pericyte migration promotes pathological neovascularization in ischemic retinopathy |
Q51550186 | PACAP Is Protective in a Rat Model of Retinopathy of Prematurity. |
Q54338867 | Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system. |
Q35210888 | Retracted: Nuclear Factor Kappa-B Signaling Is Integral to Ocular Neovascularization in Ischemia-Independent Microenvironment |
Q34637708 | Retracted: The Nexus between VEGF and NFκB Orchestrates a Hypoxia-Independent Neovasculogenesis |
Q92124288 | Retraction: Inhibition of reactive gliosis prevents neovascular growth in the mouse model of oxygen-induced retinopathy |
Q34798260 | Sulodexide inhibits retinal neovascularization in a mouse model of oxygen-induced retinopathy |
Q35682603 | The HIF-1 inhibitor YC-1 decreases reactive astrocyte formation in a rodent ischemia model |
Q34635373 | The extent of synaptic stripping of motoneurons after axotomy is not correlated to activation of surrounding glia or downregulation of postsynaptic adhesion molecules. |
Q34500204 | Zinc transporter 8 (ZnT8) expression is reduced by ischemic insults: a potential therapeutic target to prevent ischemic retinopathy |